- Sunday, August 28, 2011, 22:14
- Stock Picks
Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from its boron chemistry platform. The companys lead product programs include AN2690, a topical antifungal product candidate in Phase 3 clinical development for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor in Phase ...
Full story